Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies.

Lupoli R, Di Minno A, Tortora A, Ambrosino P, Lupoli GA, Di Minno MN.

J Clin Endocrinol Metab. 2014 Jan;99(1):E143-8. doi: 10.1210/jc.2013-2965. Epub 2013 Dec 20. Review.

PMID:
24203069
2.

TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients.

Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U, De Martino E, Cimino A, Chiovato L, Agabiti-Rosei E, Castellano M.

Diabetes Care. 2009 Sep;32(9):1589-90. doi: 10.2337/dc09-0273. Epub 2009 Jun 5.

3.

Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy.

Isidro ML, Penín MA, Nemiña R, Cordido F.

Endocrine. 2007 Aug;32(1):79-82. Epub 2007 Oct 2.

PMID:
17992605
4.

Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.

Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD.

Am J Med. 1992 Jun;92(6):631-42.

PMID:
1605145
5.

Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus.

Fournier JP, Yin H, Yu OH, Azoulay L.

CMAJ. 2014 Oct 21;186(15):1138-45. doi: 10.1503/cmaj.140688. Epub 2014 Sep 22.

6.

Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes.

Díez JJ, Iglesias P.

Clin Endocrinol (Oxf). 2013 Apr;78(4):505-11. doi: 10.1111/j.1365-2265.2012.04468.x.

PMID:
22686474
7.

Thyroxine replacement therapy and circulating lipid concentrations.

Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC.

Clin Endocrinol (Oxf). 1993 May;38(5):453-9.

PMID:
8330440
8.

Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.

Price DE, O'Malley BP, Northover B, Rosenthal FD.

Clin Endocrinol (Oxf). 1991 Jul;35(1):67-9.

PMID:
1889141
9.

Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.

Rotondi M, Cappelli C, Magri F, Botta R, Dionisio R, Iacobello C, De Cata P, Nappi RE, Castellano M, Chiovato L.

Clin Endocrinol (Oxf). 2011 Sep;75(3):378-81. doi: 10.1111/j.1365-2265.2011.04042.x.

PMID:
21521311
10.

Thyreotropin levels in diabetic patients on metformin treatment.

Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti A, Zarra E, Valentini U, Leporati P, Chiovato L, Castellano M.

Eur J Endocrinol. 2012 Aug;167(2):261-5. doi: 10.1530/EJE-12-0225. Epub 2012 May 29.

11.
12.

The effect of metformin on TSH levels in euthyroid and hypothyroid newly diagnosed diabetes mellitus type 2 patients.

Dimic D, Golubovic MV, Radenkovic S, Radojkovic D, Pesic M.

Bratisl Lek Listy. 2016;117(8):433-5.

PMID:
27546693
13.

Thyrotropin suppression by metformin.

Vigersky RA, Filmore-Nassar A, Glass AR.

J Clin Endocrinol Metab. 2006 Jan;91(1):225-7. Epub 2005 Oct 11.

PMID:
16219720
14.

TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B.

J Clin Endocrinol Metab. 2001 Oct;86(10):4860-6.

PMID:
11600554
15.

Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.

Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ.

Endocr Pract. 2007 Jul-Aug;13(4):345-9.

PMID:
17669709
16.

Metformin-induced thyrotropin suppression is not associated with cardiac effects.

Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti AM, De Cata P, Salvetti M, Chiovato L, Castellano M.

Hormones (Athens). 2014 Apr-Jun;13(2):252-8.

17.

Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.

Koulouri O, Auldin MA, Agarwal R, Kieffer V, Robertson C, Falconer Smith J, Levy MJ, Howlett TA.

Clin Endocrinol (Oxf). 2011 Jun;74(6):744-9. doi: 10.1111/j.1365-2265.2011.03984.x.

PMID:
21521256
18.

Prolactin and TSH response to TRH and metoclopramide before and after l-thyroxine therapy in subclinical hypothyroidism.

Lombardi G, Iodice M, Miletto P, Merola B, Panza N, Annunziato L.

Neuroendocrinology. 1986;43(6):676-8.

PMID:
3093910
19.

Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.

Rieu M, Richard A, Rosilio M, Laplanche S, Ropion V, Fombeur JP, Berrod JL.

Clin Endocrinol (Oxf). 1994 Apr;40(4):529-35.

PMID:
8187321
20.

Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.

Mousavi Z, Dourandish L, Rokni H, Sadeghi R, Rasoul Zakavi S.

Minerva Endocrinol. 2014 Mar;39(1):59-65.

PMID:
24513605

Supplemental Content

Support Center